FDA Limits Access to COVID Vaccination

The Food and Drug Administration announced that going forward, access to vaccination against COVID will be limited to people 65 or older and people at high risk serious illness if infected.

Vaccine manufacturers will be required to conduct additional clinical trials to prove the vaccines are beneficial for healthy people who are below 65 years old.

This policy change appears to be driven by newly appointed FDA Commissioner Marty Makary, Director of the Center for Biologics Evaluation and Research Vinay Prasad and Secretary of the Department of Health and Human Services Robert F. Kennedy Jr. Anti-vaccination beliefs and disdain for governmental response in the early years of the COVID pandemic are prominent in their stances.

Makary and Prasad say this change will bring COVID booster eligibility in the USA in line with other high-income countries. Other countries are not demanding extra clinical trials of the vaccines with younger, healthier people, so the new FDA policy is moving out of step in that regard.

Rates of long term disability have been rising fastest in countries that were quickest to reduce pandemic precautions and vaccinations, a factor the FDA does not mention.

Click here for more details.